Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Gabapentin tablets versus capsules: a review of the evidence regarding appropriate use
2010	HAYES, Inc.	Computed Tomography (CT)-guided lung biopsy with the superDimension i-Logica System (superDimension Inc.)
2010	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis and treatment of secondary lymphedema
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Eden alternative and green house concept of care: review of clinical effectiveness, cost-effectiveness, and guidelines
2010	Canary Health Service	[Efficacy and effectiveness of competitive employment strategies as a therapeutic intervention for people with disabilities due to severe and persistent mental disorders]
2010	Agency for Healthcare Research and Quality (AHRQ)	Consideration of evidence on antiemetic drugs for nausea and vomiting associated with chemotherapy or radiation therapy in adults
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Afatinib for advanced and/or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation - first line
2010	NIHR Health Technology Assessment programme	Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bifocal lenses under +0.50 diopter: a review of the clinical effectiveness and guidelines
2010	Canary Health Service	[Efficacy, effectiveness and efficiency of assertive community treatment for people with severe and persistent mental disorder and its relationship with the context of application]
2010	Agency for Healthcare Research and Quality (AHRQ)	Bone morphogenetic protein: the state of the evidence of on-label and off-label use
2010	NIHR Horizon Scanning Centre (NIHR HSC)	AIN-457 for posterior uveitis
2010	Medical Advisory Secretariat (MAS)	KRAS testing for anti-EGFR therapy in advanced colorectal cancer : an evidence-based and economic analysis
2010	NIHR Health Technology Assessment programme	Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pre-operative screening and post-operative monitoring in adult patients with obstructive sleep apnea: clinical effectiveness and guidelines
2010	Health Services Assessment Collaboration (HSAC)	The role of high-risk human papillomavirus testing for managing women with glandular abnormalities on cytology
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Apixaban for stroke prevention in atrial fibrillation
2010	Medical Advisory Secretariat (MAS)	Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer : an evidence-based and economic analysis
2010	NIHR Health Technology Assessment programme	Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sternal talon for cardiac surgery patients: a review of the clinical effectiveness and guidelines
2010	Canary Health Service	[Evaluation of an intervention on smoking in secondary education. ITES Program]
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Protein-sparing modified fast diet: efficacity, safety and clinical use - literature review]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Risk factor analysis and probability of fragility fracture in a cohort of women with bone densitometry indication]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Axitinib for advanced and/or metastatic renal cell carcinoma - second line
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tinnitus retraining therapy: a review of the clinical effectiveness
2010	Health Services Assessment Collaboration (HSAC)	Interventions to mitigate the effects of low health literacy
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) in combination with trastuzumab and docetaxel for metastatic HER2 positive breast cancer - first line
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pre-hospital phlebotomy for patients with urgent conditions: a review of the clinical effectiveness and guidelines
2010	Canary Health Service	[Antidepressant drugs and psychological treatments for depressive disorders: an economic review and evaluation]
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[External evaluation of cancer care organization and delivery: review of experiences relevant to the cancer team evaluation and designation process in Québec]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Erlotinib hydrochloride (Tarceva) for advanced non-small cell lung cancer with activating EGFR mutations - first line
2010	Blue Cross Blue Shield Association (BCBS)	Low-level laser therapy for carpal tunnel syndrome and chronic neck pain
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Laser refractive surgery in children: a review of the clinical effectiveness and guidelines
2010	Canary Health Service	[Decision-making aid tools for patients with depression]
2010	Institute of Health Economics (IHE)	Sexual exploitation of children and youth over the internet: a rapid review of the scientific literature
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Lenalidomide (Revlimid) for newly diagnosed multiple myeloma
2010	Blue Cross Blue Shield Association (BCBS)	Radiofrequency ablation of nondysplastic or low-grade dysplastic barrett's esophagus
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Laparoscopic sleeve gastrectomy: a review of the clinical benefits and harms
2010	Canary Health Service	[Impact of economic evaluation of health technologies on health decisions: a survey of decision-makers]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Pegaptanib sodium (Macugen) for diabetic macular oedema
2010	Institute of Health Economics (IHE)	Treatment for convicted adult male sex offenders
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Lenalidomide (Revlimid) for myelodysplastic syndrome
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Filtered needles for withdrawing medication from glass ampoules: a review of the cost-effectiveness and incidence of complications
2010	Canary Health Service	[Group psychotherapies as a therapeutic technique in people with schizophrenia]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Pemetrexed disodium (Alimta) for recurrent or newly diagnosed metastatic head and neck cancer
2010	Institute of Health Economics (IHE)	Means restriction for suicide prevention
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Loxapine inhalation (Staccato loxapine) for agitation associated with schizophrenia or bipolar disorder
2010	Blue Cross Blue Shield Association (BCBS)	Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Periodontal regenerative procedures for patients with periodontal disease: a review of clinical effectiveness
2010	Canary Health Service	[Systematic review of the effectiveness and cost-effectiveness of psychoeducational interventions in people with bipolar disorder and their families]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Dental indications for standardised procedures of instrumental functional analysis under consideration of health economic aspects]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Rivaroxaban (Xarelto) for prevention of venous thromboembolism in medically ill patients
2010	Institute of Health Economics (IHE)	Telehealth in substance abuse and addiction: review of the literature on smoking, alcohol, drug abuse and gambling
2010	NIHR Horizon Scanning Centre (NIHR HSC)	OncoVEX GM-CSF for unresectable metastatic melanoma - first and second line treatment
2010	Blue Cross Blue Shield Association (BCBS)	Percutaneous tibial nerve stimulation for the treatment of voiding dysfunction
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Completely-in-the-canal and bone anchored hearing aids: a review of the clinical effectiveness and cost-effectiveness
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Fecal calprotectin: diagnostic marker and treatment assessment in bowel inflammatory disease]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Tafamidis for transthyretin amyloid polyneuropathy
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Oral calcitonin for osteoarthritis of the knee in men and postmenopausal women - first line
2010	Blue Cross Blue Shield Association (BCBS)	Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Critical incident stress debriefing for first responders: a review of the clinical benefit and harm
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Telaprevir (VX-950) for hepatitis C
2010	NIHR Horizon Scanning Centre (NIHR HSC)	RG7204 for BRAF V600E mutation positive metastatic malignant melanoma - first or second line
2010	Blue Cross Blue Shield Association (BCBS)	Proton beam therapy for non-small-cell lung cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cognitive behavioural therapy for patients with addictions: a review of the clinical and cost-effectiveness
2010	Canary Health Service	[Cost-effectiveness analysis of prostate cancer screening with prostate-specific antigen associated or not with digital rectal examination in men aged 50 years and older]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Amifampridine (Firdapse) for the treatment of Lambert Eaton Myasthenic Syndrome]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Tobramycin inhaled powder (TIP) for Pseudomonas aeruginosa infection in cystic fibrosis
2010	Andalusian Health Technology Assessment Area (AETSA)	[Utility of 90Y-Ibritumomab Tiuxetan (Zevalin) in the treatment of adult patients with non-Hodgkin lymphoma]
2010	Health Council of the Netherlands Gezondheidsraad (GR)	Fitness to drive. Proposal for some changes in the Regeling eisen geschiktheid 2000
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Ruxolitinib for myelofibrosis - first line
2010	Blue Cross Blue Shield Association (BCBS)	Proton beam therapy for prostate cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Atypical antipsychotics for the treatment of schizophrenia: a review of combination therapy and high-dosing strategies
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Azacitidine (Vidaza) for the treatment of myelodysplastic syndromes]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Zibotentan for metastatic castration resistant prostate cancer - first line
2010	Andalusian Health Technology Assessment Area (AETSA)	[Vaccine for the prevention of Alzheimer's disease]
2010	Adelaide Health Technology Assessment (AHTA)	Unattended sleep studies in the diagnosis and reassessment of obstructive sleep apnoea
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Taspoglutide for type 2 diabetes mellitus - add-on therapy
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tramadol compared with opioids for pain: a review of addiction potential
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[New-onset diabetes and antihypertensive treatment]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Asenapine (Saphris) for manic episodes associated with bipolar l disorder
2010	Health Council of the Netherlands Gezondheidsraad (GR)	Fitness to drive. Proposal for some changes in the Regeling eisen geschiktheid 2000
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Trastuzumab (Herceptin) for HER2 positive early, locally advanced and inflammatory breast cancer - neoadjuvant treatment
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Percutaneous heart valve replacement for valvular heart disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Asenapine (Saphris) for schizophrenia
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Vorapaxar for acute coronary syndrome
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cognitive behavioural therapy for post traumatic stress disorder: a review of the clinical and cost-effectiveness
2010	NIHR Health Technology Assessment programme	Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Invasive home mechanical ventilation, mainly focused on neuromuscular disorders]
2010	Medical Advisory Secretariat (MAS)	Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Dapagliflozin (BMS 512148) for type 2 diabetes mellitus - add on therapy
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Vorapaxar for secondary prevention of cardiovascular events
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Rituximab for non-hodgkin's lymphoma: a review of the clinical and cost- effectiveness and guidelines
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers]
2010	Medical Advisory Secretariat (MAS)	Solid organ transplantation for End Stage Organ Failure (ESOF) in persons with HIV
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Galsulfase (Naglazyme) for the treatment of mucopolysaccharidosis type VI]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Lapatinib plus paclitaxel for metastatic breast cancer - first line
2010	Andalusian Health Technology Assessment Area (AETSA)	[Tool for the assessment of drugs for the treatment of inborn errors of metabolism. Anderson- Fabry disease]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Zoledronic acid (Zometa) for hormone-receptor-positive early breast cancer - adjuvant therapy